Chimerix announced the appointment of Thomas Riga as Chief Operating and Commercial Officer. Prior to joining Chimerix, Riga served as President and Chief Executive Officer at Spectrum Pharmaceuticals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CMRX:
- Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
- Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
- Chimerix reports Q3 EPS (27c), consensus (23c)
- Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023